Skip to Content
Merck

1.00128

Aurin tricarboxylic acid ammonium salt

GR for analysis (reagent for aluminium) ACS

Synonym(s):

Aurin tricarboxylic acid ammonium salt, Aluminon, Ammonium aurin tricarboxylate

Sign In to View Organizational & Contract Pricing.

Select a Size

All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C22H23N3O9
CAS Number:
569-58-4
Molecular Weight:
473.43
UNSPSC Code:
12352107
EC Index Number:
209-319-1
NACRES:
NA.21
MDL number:
MFCD00040925
grade:
ACS reagent
assay:
≥97% (HPLC)

Product Name

Aurin tricarboxylic acid ammonium salt, GR for analysis (reagent for aluminium) ACS

InChI

1S/C22H16O9.3H3N/c23-16-4-1-10(7-13(16)20(26)27)19(11-2-5-17(24)14(8-11)21(28)29)12-3-6-18(25)15(9-12)22(30)31;;;/h1-10,19,24-25H,(H,26,27)(H,28,29)(H,30,31);3*1H3

InChI key

UDPQMNAHKKTHHI-UHFFFAOYSA-N

grade

ACS reagent

assay

≥97% (HPLC)

form

solid

potency

9000 mg/kg LD50, oral (Rat)

manufacturer/tradename

Calbiochem®

dilution

(for analytical testing)

pH

5.3 (20 °C, 10 g/L in H2O)

mp

220-225 °C (decomposes)

bulk density

400 kg/m3

shipped in

ambient

storage temp.

2-8°C

Quality Level

100

Related Categories

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Analysis Note

Assay (acidimetric, calc. on anhydrous substance): ≥ 98
Identity (IR-spectrum): passes test
Insoluble matter: ≤ 0.1 %
Water (according to Karl Fischer): ≤ 10
Sulfated ash: ≤ 0.2 %
Suitability as reagent (for aluminium): passes test

Disclaimer

Toxicity: Carcinogenic / Teratogenic (D)

Storage Class

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Alexander J Valvezan et al.
JCI insight, 5(7) (2020-04-10)
Recent studies in distinct preclinical tumor models have established the nucleotide synthesis enzyme inosine-5'-monophosphate dehydrogenase (IMPDH) as a viable target for antitumor therapy. IMPDH inhibitors have been used clinically for decades as safe and effective immunosuppressants. However, the potential to

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service